Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability
- 5 August 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 333 (3), 1011-1016
- https://doi.org/10.1016/j.bbrc.2005.06.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Insulin‐like growth factor ligands, receptors, and binding proteins in cancerThe Journal of Pathology, 2005
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3Biochemical and Biophysical Research Communications, 2004
- Matrix Metalloproteinase 19 Regulates Insulin-like Growth Factor-mediated Proliferation, Migration, and Adhesion in Human Keratinocytes through Proteolysis of Insulin-like Growth Factor Binding Protein-3Molecular Biology of the Cell, 2003
- Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3Journal of Biological Chemistry, 1997
- Involvement of IGF-II in human cancerJournal of Endocrinology, 1996
- Role of insulin-like growth factor binding proteins in the control of IGF actionsProgress in Growth Factor Research, 1995
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- Polyamine‐dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer—derived cell lineMolecular Carcinogenesis, 1994
- Expression and localization of the matrix metalloproteinase pump‐1 (MMP‐7) in human gastric and colon carcinomasMolecular Carcinogenesis, 1991